Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Henry M. Jackson Foundation licenses vaccine for Nipah and Hendra viruses


By Jesse Schwartz
Published: May 30th, 2018

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) has licensed out a vaccine for Nipah virus and Hendra virus.

Awarded through the Joint Technology Transfer Office of HJF and Uniformed Services University (USU), the license goes to Profectus BioSciences and Emergent BioSolutions, which will collaborate to develop the human vaccine for the two viruses.

Nipah and Hendra are found naturally in several species of Pteropid fruit bats. Recent Nipah outbreaks in India have caused acute respiratory distress syndrome and encephalitis, with higher than 75% fatality rates among humans.

The vaccine from HJF received support from the National Institutes of Health and has already shown in multiple animal models to be completely protective against both the Nipah and Hendra viruses.

“It is a single dose, extremely safe, simple and highly effective vaccine that has proven time and time again to provide complete protection against two incredibly deadly viral pathogens that are a biological threat to not only people but important livestock as well,” says Christopher Broder, a USU researcher and co-developer of the vaccine.

The license agreement will also enable funding of up to $25 million for the development of the vaccine over a five-year period.

Source: GlobeNewswire

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment